동시개최
2009년 11월 2일∼3일

제7회 연차 
세포경로 및 표적 스크리닝을 위한 RNAi
Seventh Annual
RNAi for Screening Cellular pathways and Target

제3회 연차
HDAC 저해제
Third Annual
HDAC Inhibitors

제4회 연차
치료표적으로써의 이온채널
Fourth Annual
Ion Channels as Therapeutic Taegets

제4회 연차
GPCR을 이용한 창약
Fourth Annual
GPCR-Based Drug Discovery

동시개최
2009년 11월 3일∼4일

제3회 연차
표적치료 개발을 위한 RNAi
Third Annual
RNAi for Diveloping Targeted Therapeutics

제3회 연차
키나아제 저해제
Third Annual
Kinase Inhibitors

제2회 연차
신규 치료약에 의한 당뇨병 표적치료
Second Annual
Targeting Diabetes with Novel Therapeutics

프리컨퍼런스
쇼트코스
2009년 11월 1일

Strategies for Effective RNAi Screens

Targeting GPCRs and Ion Channels with Antibodies

Strategies for Optimizing RNAi Delivery

Combating Diabetes with Strategies for Enhanced Pancreatic Beta Cell Survival and Regeneration

Structure-Based Design of Ion Channels

Cardiovascular Safety in Drug Development - From Preclinical to Phase I

KEYNOTE PRESENTERS

 David Clapham, M.D., Ph.D.,
Howard Hughes Medical Institute





 Michael Dabrowski, Ph.D.,
AstraZeneca





 Gregory J. Kaczorowski,
School; Robert Wood Johnson Medical School





 John M. Maraganore, Ph.D.,
Alnylam Pharmaceuticals, Inc.





 Graeme Milligan, Ph.D.,
University of Glasgow





 Steven E. Nissen, M.D.,
M.A.C.C., Cleveland Clinic Foundation





David Root, Ph.D.,
The RNAi Consortium Broad Institute of MIT and Harvard

Anja J. Stauber, Ph.D., DABT,
Eli Lilly and Company

Eric M. Verdin, M.D.,
University of California, San Francisco